WENDI HELSABECK: Open Payments
NPI 1992271209 · GALAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 29 payments from 14 companies in 2025. Trend: 2023 $49 · 2024 $611 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| Paratek Pharmaceuticals, Inc. | 4 | $57 |
| PFIZER INC. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Viatris Specialty LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Dexcom, Inc. | 1 | $33 |
| Verona Pharma, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, NURTEC ODT, TRINTELLIX, NUZYRA, BREZTRI, YUPELRI, Wegovy, CAPLYTA.
Industry payments across VA — which companies pay providers there.
